鸡降钙素真核表达质粒pCEP4-CT的构建及细胞表达

构建重组鸡降钙素真核表达载体pCEP4-CT,转染非洲绿猴肾细胞(COS-1)并检测其表达。通过酶切方法自含鸡降钙素(CT)基因的克隆质粒pGEM-T-CT中扩增CT基因,并将其克隆到真核表达载体pCEP4中。阳性克隆鉴定后,在PEI介导下转染非洲绿猴转化肾细胞(COS-1),通过间接免疫荧光试验(IFA)检测CT在COS-1中的表达状况。结果表明,所获重组质粒经过酶切、测序鉴定,证实含有目的片段,且连接、构建正确;在COS-1细胞中检测到了CT的表达,为进一步探讨该基因在动物机体中调控钙代谢奠定了基础。     

小鼠骨骼肌Desmin启动子的克隆及表达活性分析

为了研究在体细胞中小鼠Desmin基因启动子是否具有表达活性,试验根据NCBI中小鼠Desmin启动子的序列,利用生物软件Primer Premier 6.0设计序列上、下游引物,克隆小鼠基因组中Desmin启动子片段,将克隆到的Desmin启动子片段与pAcGFP1-N1载体中的CMV启动子进行置换以构建真核表达载体pAcGFP1-N1-Des,然后将pAcGFP1-N1-Des依次转染CHO-K1、COS-7、293GP和NIH-3T3等细胞后,观察绿色荧光蛋白表达活性。结果表明:克隆得到的Desmin基因上游启动子(841 bp)与NCBI序列(NT_039173.7)比对同源性为99.76%;克隆得到的启动子中含有CAAT-box、GC-box核心调控区以及MyoD等多种转录因子结合位点;所构建的pAcGFP1-N1-Des经转染COS-7、CHO-K1和Hela细胞后可观察到呈现表达活性的绿色荧光。说明克隆获得了在COS-7、CHO-K1以及Hela细胞中的具有表达活性的小鼠Desmin基因启动子。     

PRRSV清道夫受体CD163基因的真核表达和功能鉴定

从猪肺泡巨噬细胞(PAM)中提取总RNA为模板,采用RT-PCR法获得猪繁殖与呼吸综合征病毒(PRRSV)的受体CD163全基因,将该基因克隆到真核表达载体pcDNA3.1/V5-HIS A上,构建出真核重组质粒pcDNA3.1-CD163,经酶切和DNA测序证明获得了CD163基因,其序列与GenBank报道序列比较,核苷酸同源性为99.37%。将测序正确的CD163基因在脂质体LipofectamineTM2000介导下转染PK-15细胞,通过间接免疫荧光(IFA)检测到了CD163在PK-15中的表达。将转染的细胞感染PRRSV后,经IFA检测转染CD163的细胞能够被PRRSV感染。     

猪新基因CFL2真核表达载体的构建及在C2C12细胞中的瞬时表达

从猪的股二头肌中提取总RNA,利用RT-PCR技术从猪骨骼肌中获得CFL2基因的编码区序列,T-A克隆至PMD-18T载体,经HindⅢ和XhoⅠ酶切后定向克隆至真核表达载体pCDNA3.1(+)中。获得的重组质粒pCDNA3.1(+)/CFL2用限制性内切酶酶切分析和DNA测序分析鉴定,并经脂质体瞬时转染C2C12细胞,最后利用PCR检测转基因细胞中CFL2基因的存在及其表达情况。结果显示:猪CFL2基因已克隆到真核表达载体pCDNA3.1(+)中,转染的C2C12细胞中检测到细胞内较高量CFL2的表达。pCDNA3.1(+)/CFL2真核表达载体的成功构建,为深入研究CFL2基因在猪肌肉细胞中的功能奠定基础,为猪肉质品质的改良提供了新的思路。     

皮蝇 Hypodermin C 基因的克隆及重组表达载体的构建

参照牛皮蝇 Hypodermin C(HC)基因的核苷酸序列，设计了1对引物，以牛皮蝇总RNA为模板，用RT-PCR扩增了牛皮蝇HC基因，将扩增基因进行克隆测序。测序结果表明，所获得基因与已知序列同源性达99．45％。同时，将该基因与表达载体pGEX-4T-1连接，构建并获得阳性重组表达载体。     

奶牛LAP基因真核表达载体的构建及其在COS-7细胞中的瞬时表达

根据GenBank上发表的牛舌抗菌肽(Lingual antimicrobial peptide,LAP)基因cDNA序列设计1对特异引物,从患乳腺炎的奶牛乳腺组织中以RT-PCR方法扩增LAP基因片段,将其克隆到pMD19-T Simple载体中测序。重组质粒经EcoRⅠ+BamHⅠ双酶切回收目的基因片段,亚克隆入增强型绿色荧光蛋白表达载体pEGFP-C1中构建重组融合表达质粒pEGFP-LAP,将其脂质体转染COS-7细胞,经荧光显微镜观察到融合表达的绿色荧光蛋白,采用RT-PCR检测到LAP基因在COS-7细胞中转录。pEGFP-LAP重组表达质粒的成功构建为进一步研究奶牛LAP基因的表达特性及利用基因工程技术防治奶牛乳腺炎奠定了基础。     

传染性法氏囊病病毒JS株VP2基因真核表达载体的构建及其应用

应用RT-PCR方法从鸡传染性法氏囊病病毒(IBDV)JS株中扩增出VP2基因,并克隆入T-easy载体。序列测定分析结果表明IBDVJS株的VP2基因与国际标准强毒株的核苷酸序列同源性达98%,氨基酸序列同源性达99%以上。随后将VP2基因克隆入真核表达载体pcDNA3.1/zeo( ),构建成功真核表达质粒pcD-VP2,pcD-VP2体外转染COS-1细胞,能在COS-1细胞中表达。利用pcD-VP2质粒进行动物实验,结果表明雏鸡免疫14d后在体内可检测到特异性抗体,pcD-VP2的真核表达质粒二次免疫诱导鸡产生对IBDV强毒攻击的保护率为67%,这一结果提示VP2基因具有重要开发应用价值。     

禽呼肠孤病毒广西分离株σ3基因的克隆和表达

采用RT_PCR技术扩增禽呼肠孤病毒广西分离株R1σ3基因,将σ3基因克隆至PGEX_4T_1载体上,测序结果表明插入的片段为σ3目的基因。切下目的基因σ3,重组到含有谷胱甘肽(GST)的融合蛋白质粒表达载体PGEX_4T_1,获得重组质粒经PCR酶切以及序列分析鉴定,表达σ3基因插入的位置,大小和阅码框架均正确,表明成功构建了融合表达载体PGEX_R1_σ3。构建好的重组质粒,经1mmol/LIPTG诱导,在大肠杆菌DH5α中得到了表达。融合蛋白GST_R1_σ3的分子量为60ku,以包涵体形式存在。Westernblot分析表明,融合蛋白能够与ARV阳性血清发生特异性反应,表明该重组蛋白具有良好的抗原性和特异性。     

耐药性大肠杆菌整合子整合酶的克隆与表达

为获得纯化的大肠杆菌Ⅰ类整合子整合酶,采用PCR技术扩增目的基因,将目的基因克隆到pEASY-T1载体上测序,测序结果与NCBI上公布的耐药性大肠杆菌Ⅰ类整合子整合酶基因完全一致后,再将目的基因克隆到表达载体pEASY-E1 Expression上,将表达质粒载体转化于rosetta感受态细胞中诱导表达,经SDS-聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质印迹(Western-blot)检测分析。结果表明:表达产物分子量为33 ku,与耐药性大肠杆菌Ⅰ类整合子整合酶分子量一致,为进一步测定酶的活性提供物质基础。     

猪EP1基因的克隆与原核表达

为进一步体外研究EP1基因的生物学功能,本试验对EP1基因进行了组织分布分析。以猪骨髓cDNA为模板克隆了猪EP1基因的开放阅读框,对克隆的基因序列进行了序列分析,用非酶连接技术将此基因克隆至丙酸诱导型原核表达载体pBbB3a-His6-MBP-LIC中。用菌液PCR进行阳性克隆鉴定并测序,将测序鉴定正确的克隆菌液提取质粒,转化至E.coli BL21(DE3)中。丙酸钠诱导表达His6-MBP-EP1融合蛋白,并用Western blot进行鉴定。结果显示:本试验成功克隆了猪EP1基因,长度为651bp,猪EP1基因在骨髓中的表达量很高;构建了EP1丙酸诱导型原核表达载体pBbB3a-His6-MBP-EP1;His6-MBP-EP1融合蛋白在裂解菌液的上清中表达,相对分子质量为65560。结果表明,运用大肠杆菌表达系统成功表达EP1基因融合蛋白,为进一步在体外开展猪EP1基因生物学功能的研究提供基础。     

禽多杀性巴氏杆菌ompa DNA疫苗在小鼠体内免疫效果试验

应用PCR技术扩增获得禽多杀性巴氏杆菌的ompa基因片段,克隆到pUCm-T载体,再亚克隆到真核表达质粒载体pCDNA3.1(+)上,构建重组质粒pcA,体外转染Vero细胞,RT-PCR和间接免疫荧光试验检测其转录表达情况。动物免疫分为3组:pCDNA3.1(+)组、PBS对照组和pcA组,每组16只BALB/c小鼠,pCDNA3.1(+)组和pcA组以100μg/只的剂量肌注免疫,PBS组每只小鼠肌注100μL 1×PBS,各组均免疫3次,每次间隔2周。间接ELISA检测免疫后小鼠血清特异性抗体水平,MTT法检测免疫小鼠脾淋巴细胞增殖情况,三免2周后检测脾淋巴细胞IFN-γ分泌情况。强毒攻击,计算小鼠存活数目及保护率。结果显示,间接免疫荧光试验和RT-PCR检测结果均表明pcA可在体外培养的Vero细胞中表达目的蛋白。动物免疫后,pcA组免疫小鼠血清抗体水平持续上升,与pCDNA3.1(+)组和PBS组相比差异极为显著(P<0.01)。经提取的禽多杀性巴氏杆菌总外膜蛋白(Omps)刺激后,pcA组的刺激值(SI值)与pCDNA3.1(+)组及PBS免疫组相比均差异显著(P<0.05)。脾细胞产生的IFN-...     

H7亚型禽流感病毒血凝素基因的真核表达载体的构建及鉴定

参考已发表的H7亚型禽流感病毒(AIV)血凝素(HA)基因序列设计引物,以pUCH7为模板,经PCR扩增出一条1.7kb的HA全基因片段,将该片段定向克隆到真核表达质粒载体pcDNA3.1(一)中,转化大肠埃希氏菌DH5α,小量制备重组质粒pcDNA-HA,酶切鉴定正确后,转染COS-1细胞,经免疫荧光鉴定其体外表达情况。结果表明H7亚型AIV HA在COS-1细胞中获得了成功表达。用该重组质粒pcDNA-HA免疫BALB／C小鼠,制备免疫血清,经免疫印迹实验证实该H7亚型AIV HA在小鼠体内也得到了良好的表达。     

牛乳铁蛋白肽基因LfcinB的合成及真核表达载体的构建

根据APD抗菌肽数据库报道的牛乳铁蛋白肽LfcinB氨基酸序列,合成编码LfcinB基因的2条互补的寡核苷酸链,退火后在5′端和3′端分别形成含有BamH I和Xho I位点粘性末端的双链DNA。真核表达载体pcDNA3.1（+）经BamH I 和Xho I限制性内切酶双酶切处理后与合成的LfcinB基因进行连接,连接产物转化E.coli DH5α感受态细胞,提取质粒DNA进行测序。测序结果显示,牛乳铁蛋白肽LfcinB基因成功克隆到pcDNA3.1（+）真核表达载体中,为进一步表达和抗菌活性研究奠定物质基础。     

猪圆环病毒2型CC株ORF3基因序列分析及真核表达

根据GenBank中猪圆环病毒2型(PCV2)的核酸序列,设计了1对引物,采用PCR方法从疑似断奶仔猪多系统衰竭综合征(PMWS)的死亡仔猪病料中扩增出了ORF3基因,将其克隆到高效真核表达载体pEGFP- N2中,筛选出含有ORF3基因的重组质粒,命名为pEGFP-N2-ORF3.对此重组质粒进行测序分析,结果表明,克隆的ORF3基因与其他PCV2的ORF3核苷酸序列相似性为96.2％-99.0％,氨基酸序列同源性为90.5 ％～98.1％.将重组质粒纯化后转染COS-7细胞,用PCR方法扩增出了特征性的基因片段,并采用特异性单抗进行间接免疫荧光,结果转染pEGFP- N2-ORF3重组蛋白在细胞核和细胞浆中均有表达,尤其在细胞核中表达量较高,且对细胞有一定的毒性.本研究为进一步探讨ORF3的结构和功能提供理论依据.     

伪狂犬病病毒蛋白激酶基因部分序列的克隆和序列测定及转移质粒载体的构建

以伪狂犬病病毒SH株细胞培养物为模板，用PCR方法扩增蛋白激酶(PK)基因部分片段，克隆到pCDNA3中，序列测定显示所扩增的PK基因片段长907bp，与PRVNIA-3株的核苷酸同源性为99．6％。把PK基因克隆到pUCl9上，利用PK基因中间的SalI酶切位点，插入带有绿色荧光蛋白(EGFP)的基因表达盒，构成了含EGFP的转移载体，为今后研究PK基因的功能和构建PK缺失株奠定了基础。     

Validation of a Rapid Parathyroid Hormone Assay and Intraoperative Measurement of Parathyroid Hormone in Dogs with Benign Naturally Occurring Primary Hyperparathyroidism

Objectives— To (1) validate a rapid chemiluminescent parathyroid hormone (PTH) assay, (2) determine it's usefulness locating a parathyroid nodule(s), and (3) determine if >50% decrease in PTH corresponds with excision of autonomously functioning parathyroid tissue. Study Design— Prospective cohort study. Animals— Dogs (n=12) with naturally occurring primary hyperparathyroidism and 25 healthy dogs. Methods— The assay was validated with linearity, precision, and intermethod comparison. Preoperative and postoperative systemic plasma PTH concentrations, measured from saphenous venous blood, were compared. Intraoperative local PTH concentrations were measured in right and left jugular venous blood before and after surgical excision of the grossly abnormal parathyroid gland(s). Results— Within run and day‐to‐day precisions were acceptable (coefficient of variation <15%). Dilutional parallelism was used to demonstrate high correlation between measured and calculated PTH concentrations (R²=0.99). The assay methods had good correlation but numerical results of the rapid assay were usually lower than the immunoradiometric assay. Seven of 12 dogs had uniglandular disease and five had multiglandular disease. Systemic and local PTH concentrations decreased >50% in all the dogs after excision of the parathyroid gland(s). Mean preoperative systemic plasma PTH concentrations were significantly higher than mean postoperative systemic concentrations. Local PTH concentrations could not be used reliably to differentiate the side of the autonomously functioning gland(s). Hypercalcemia resolved postoperatively in all the dogs. Conclusion— This assay measures PTH in dogs. Rapid PTH measurement provided documentation of decreased PTH concentration after removal of autonomously functioning parathyroid tissue. Clinical Relevance— Use of this assay allows documentation of a significant decrease in PTH concentration after excision of autonomously functioning parathyroid tissue.     

人血清白蛋白载体的构建及其在山羊乳腺中的瞬时表达

根据GeneBank中人血清白蛋白(HSA)的基因序列,设计一对特异性的引物,从人肝cDNA文库中扩增出其编码序列,并加入酶切位点XhoⅠ,以pCDNA 3.1为模板,设计特异性的引物,并在上游引物加入NotⅠ,下游加入ApaⅠ和NotⅠ,扩增出筛选标记新霉素抗性基因neo,然后再以pBC1为基本骨架,在其NotⅠ、XhoⅠ位点处分别插入hsa和neo,从而得到乳腺表达载体pBC-NEO-HSA,将该质粒注射入奶山羊乳腺中进行暂时性的表达,结果显示所构建的载体能够有效地指导目的基因的表达,从而为下一步构建细胞系、克隆动物作好基础。     

Cloning and sequence analysis of the complementary DNA for feline preproparathyroid hormone

OBJECTIVES: To clone and sequence the cDNA for feline preproparathyroid hormone (preproPTH) and to compare that sequence with other known parathyroid hormone (PTH) sequences. SAMPLE POPULATION: Parathyroid glands from 1 healthy cat. PROCEDURES: A cDNA library was constructed in lambda phage from feline parathyroid gland mRNA and screened with a radiolabeled canine PTH probe. Positive clones were sequenced, and nucleic acid and deduced amino acid sequences were analyzed and compared with known preproPTH and PTH sequences. RESULTS: Screening of approximately 2 X 10(5) recombinant plaques revealed 3 that hybridized with the canine PTH probe; 2 clones comprised the complete sequence for feline preproPTH. Feline preproPTH cDNA consisted of a 63-base pair (bp) 5'-untranslated region (UTR), a 348-bp coding region, and a 326-bp 3'-UTR. The coding region encoded a 115-amino acid peptide. Mature feline PTH consisted of 84 amino acids. Amino acid sequence analysis revealed that feline PTH was > 83% identical to canine, bovine, swine, equine, human, and macaque PTH and 69, 71, and 44% identical to mouse, rat, and chicken PTH, respectively. Within the region responsible for hormonal activity (amino acids 1 to 34), feline PTH was > 79% identical to other mammalian PTH sequences and 64% identical to the chicken sequence. CONCLUSIONS AND CLINICAL RELEVANCE: The amino acid sequence of PTH is conserved among mammalian species. Knowledge of the cDNA sequence for feline PTH may be useful to investigate disturbances of calcium metabolism and alterations in PTH expression in cats.